Back
Intellia Therapeutics Stock Price Chart

10 stocks to buy for the next leg of this rally
Get the full list here FREE
Sell
13
NTLA
Intellia Therapeutics
Last Price:
$6.86
Seasonality Move:
17.23%
7 Day Trial
ALL ACCESS PASS
$
7

10 Best Stocks to Own in 2025
Get your copy now FREE!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
Intellia Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.85 | Sell |
20-day SMA: | 8.47 | Sell |
50-day SMA: | 8.05 | Sell |
200-day SMA: | 13.54 | Sell |
8-day EMA: | 8.38 | Sell |
20-day EMA: | 8.46 | Sell |
50-day EMA: | 8.59 | Sell |
200-day EMA: | 13.28 | Sell |
Intellia Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 38.33 | Sell |
Chaikin Money Flow: | -7673207 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.74 - 9.22) | Sell |
Bollinger Bands (100): | (7.7 - 10.7) | Sell |
Intellia Therapeutics Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 6.87 while NTLA 8-day simple moving average is 8.85, which is a Sell signal.
-
The stock price of NTLA is 6.87 while Intellia Therapeutics 20-day SMA is 8.47, which makes it a Sell.
-
Intellia Therapeutics 50-day simple moving average is 8.05 while NTLA share price is 6.87, making it a Sell technically.
-
NTLA stock price is 6.87 and Intellia Therapeutics 200-day simple moving average is 13.54, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
13
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $6.87. The Score for NTLA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
711.6M
Price in USD:
6.87
Share Volume:
8.9M
Intellia Therapeutics 52-Week Range
52-Week High:
28.18
52-Week Low:
5.90
Sell
13
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 6.87 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 6.87 while NTLA 8-day exponential moving average is 8.38, which is a Sell signal.
-
The stock price of NTLA is 6.87 while Intellia Therapeutics 20-day EMA is 8.46, which makes it a Sell.
-
Intellia Therapeutics 50-day exponential moving average is 8.59 while NTLA share price is 6.87, making it a Sell technically.
-
NTLA stock price is 6.87 and Intellia Therapeutics 200-day simple moving average is 13.28, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.03 per share, and an increase next year of $0.29 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Intellia Therapeutics is a Buy
-
Intellia Therapeutics Relative Strength Index (RSI) is 38.33, which suggest Intellia Therapeutics is oversold
-
The Bollinger Bands (25) for Intellia Therapeutics is (7.74 - 9.22), which suggest Intellia Therapeutics is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics is (7.7 - 10.7), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.